John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$191M |
| 2 |
Intel
INTC
|
+$190M |
| 3 |
Qualcomm
QCOM
|
+$188M |
| 4 |
Procter & Gamble
PG
|
+$158M |
| 5 |
PepsiCo
PEP
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$120M |
| 2 |
Costco
COST
|
+$107M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$98.4M |
| 5 |
Eli Lilly
LLY
|
+$75.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.46% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Technology | 13.9% |
| 4 | Consumer Staples | 9.5% |
| 5 | Financials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
PUT
Smith & Wesson
SWBI
$612M
| $237K | ﹤0.01% |
14,311
+1,171
| +9% | +$10.9K |
|
|
CBMG
2527
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $237K | ﹤0.01% |
+15,851
| New | +$226K |
|
2528
PUT
Suncor Energy
SU
$78.8B
| $236K | ﹤0.01% |
+14,000
| New | +$239K |
|
|
MNDT
2529
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $236K | ﹤0.01% |
+19,400
| New | +$225K |
|
2530
PUT
HealthEquity
HQY
$8.81B
| $235K | ﹤0.01% |
4,000
-3,700
| -48% | -$205K |
|
2531
PUT
New York Times
NYT
$10.9B
| $235K | ﹤0.01% |
5,600
-1,000
| -15% | -$36.4K |
|
2532
CALL
Valero Energy
VLO
$99.6B
| $235K | ﹤0.01% |
4,000
-19,000
| -83% | -$1.13M |
|
2533
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15.2B
| $235K | ﹤0.01% |
4,000
-122,200
| -97% | -$7.13M |
|
|
CMBT
2534
CMB.TECH NV
CMBT
$5.27B
| $235K | ﹤0.01% |
+28,800
| New | +$286K |
|
2535
Badger Meter
BMI
$3.94B
| $234K | ﹤0.01% |
3,723
-4,562
| -55% | -$271K |
|
|
LYRA
2536
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $234K | ﹤0.01% |
+412
| New | +$301K |
|
2537
PUT
PG&E
PCG
$39.9B
| $234K | ﹤0.01% |
+26,400
| New | +$288K |
|
2538
PUT
NCR Voyix
VYX
$1.1B
| $234K | ﹤0.01% |
+22,005
| New | +$252K |
|
2539
Galectin Therapeutics
GALT
$391M
| $233K | ﹤0.01% |
76,190
+59,258
| +350% | +$149K |
|
2540
PUT
Keurig Dr Pepper
KDP
$44.2B
| $233K | ﹤0.01% |
+8,200
| New | +$223K |
|
2541
CALL
Labcorp
LH
$27.5B
| $233K | ﹤0.01% |
+1,630
| New | +$226K |
|
2542
Nelnet
NNI
$4.57B
| $233K | ﹤0.01% |
4,883
-3,688
| -43% | -$173K |
|
2543
Yeti Holdings
YETI
$3.14B
| $233K | ﹤0.01% |
5,449
-77,935
| -93% | -$2.34M |
|
2544
Alerus Financial
ALRS
$818M
| $232K | ﹤0.01% |
+11,746
| New | +$212K |
|
|
CLSD
2545
DELISTED
Clearside Biomedical
CLSD
| $232K | ﹤0.01% |
+8,216
| New | +$242K |
|
2546
PUT
Dine Brands
DIN
$457M
| $232K | ﹤0.01% |
+5,500
| New | +$222K |
|
2547
CALL
Nucor
NUE
$55.5B
| $232K | ﹤0.01% |
5,600
-5,000
| -47% | -$202K |
|
2548
CALL
Aon
AON
$76.2B
| $231K | ﹤0.01% |
1,200
-800
| -40% | -$149K |
|
2549
CALL
Dillards
DDS
$10B
| $230K | ﹤0.01% |
+8,900
| New | +$252K |
|
2550
CALL
iShares MSCI Brazil ETF
EWZ
$8.07B
| $230K | ﹤0.01% |
8,000
-116,200
| -94% | -$3.05M |
|
Similar funds
John Overdeck's Q2 2020 Portfolio in Review
As of Q2 2020, John Overdeck held 3,794 positions worth $20.2B, up 64% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
John Overdeck deployed $4.35B of net new capital in Q2 2020, opening 798 new positions and adding to 974 existing holdings. Its largest new stake was Kroger: 3,903,595 shares worth $132M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $104M trimmed.
- John Overdeck's largest Q2 2020 buy was Kroger: 3,903,595 shares worth $132M.
- John Overdeck added most to Lowe's Companies in Q2 2020, an estimated $191M increase.
- John Overdeck's biggest Q2 2020 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $104M.
- John Overdeck fully exited Starbucks in Q2 2020, selling an estimated $120M.
- John Overdeck's ten largest holdings make up 12% of its $20.2B portfolio in Q2 2020.
- John Overdeck opened 798 new positions and closed 913 in Q2 2020.
- John Overdeck's portfolio value rose 64% quarter-over-quarter to $20.2B.
Based on Two Sigma Investments's 13F filing for Q2 2020, filed 14 Aug 2020.